Gonzalo Saiz-Gonzalo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Gonzalo Saiz-Gonzalo has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
- Sinead B. Bleiel
AnaBio Technologies, IDA Business Park, Carrigtwohill, T45 RW24 Cork, Ireland
5 shared publications - Seamus McSweeney
AnaBio Technologies, IDA Business Park, Carrigtwohill, Co. Cork, T45 RW24, Ireland
4 shared publications - Ahmed W. Al-Humadi
Diabetes Complications Research Centre, Conway Institute, University College Dublin, D04 V1W8 Dublin, Ireland
3 shared publications - Carel Wynand le Roux
University College Dublin, Dublin, Ireland
3 shared publications - Seamus McSweeney
AnaBio Technologies, IDA Business Park, Carrigtwohill, T45 RW24 Cork, Ireland
2 shared publications - Shima Joy
AnaBio Technologies , Carrigtwohill, Co. Cork
2 shared publications
Latest Publications
- Open Access
Comparison of Two Active Doses of Microencapsulated Lacticaseibacillus rhamnosus GG in a Yoghurt Drink on Gut Microbiome Profiles in Healthy Adults: A Randomised, Double-Blind Crossover Trial
Probiotic efficacy may depend on reliable intestinal exposure, yet clinical evidence linking delivery engineering to measurable microbiome responses in humans remains limited. We compared two active doses of microencapsulated Lacticaseibacillus rhamnosus GG in 26 healthy adults in a randomised, double-blind, two-period crossover trial. Participants received 2 × 109 CFU/day (2BN) and 6 × 109 CFU/day (6BN) for 28 days each in a yoghurt drink, separated by a 14-day washout. Gastrointestinal metrics, tolerance, bowel-habit metrics, and the measured biomarkers remained stable across both doses. By metagenomics, L. rhamnosus was detected in stools in 8/23 participants at baseline, 12/23 participants after 6BN, and 10/23 after 2BN. These data represent marginal prevalence counts and does not establish individual acquisition, viability, persistence or colonisation. Species-level PERMANOVA on Aitchison distances showed a significant within-period microbiome shift during 6BN that was not observed during 2BN. There were directional changes in commensal anaerobic taxa and metagenomic functional modules related to vitamin/cofactor biosynthesis, polyamine biosynthesis, glycogen degradation, multidrug-resistance efflux pumps, and tetrahydrobiopterin biosynthesis. Microencapsulated L. rhamnosus GG was safe and well tolerated at both doses.
Open AccessComparison of Two Active Doses of Microencapsulated Lacticaseibacillus rhamnosus GG in a Yoghurt Drink on Gut Microbiome Profiles in Healthy Adults: A Randomised, Double-Blind Crossover Trial
Probiotic efficacy may depend on reliable intestinal exposure, yet clinical evidence linking delivery engineering to measurable microbiome responses in humans remains limited. We compared two active doses of microencapsulated Lacticaseibacillus rhamnosus GG in 26 healthy adults in a randomised, double-blind, two-period crossover trial. Participants received 2 × 109 CFU/day (2BN) and 6 × 109 CFU/day (6BN) for 28 days each in a yoghurt drink, separated by a 14-day washout. Gastrointestinal metrics, tolerance, bowel-habit metrics, and the measured biomarkers remained stable across both doses. By metagenomics, L. rhamnosus was detected in stools in 8/23 participants at baseline, 12/23 participants after 6BN, and 10/23 after 2BN. These data represent marginal prevalence counts and does not establish individual acquisition, viability, persistence or colonisation. Species-level PERMANOVA on Aitchison distances showed a significant within-period microbiome shift during 6BN that was not observed during 2BN. There were directional changes in commensal anaerobic taxa and metagenomic functional modules related to vitamin/cofactor biosynthesis, polyamine biosynthesis, glycogen degradation, multidrug-resistance efflux pumps, and tetrahydrobiopterin biosynthesis. Microencapsulated L. rhamnosus GG was safe and well tolerated at both doses.
- Open Access
- 20 August 2026
- Published by Walter de Gruyter GmbH in Beneficial Microbes
- p. 1-19
A high-fibre snack containing Lacticaseibacillus rhamnosus GG for healthy adults: a randomised, double-blind, placebo-controlled crossover trial
Probiotics have gained increasing evidence for their roles in health and disease. Microencapsulation can improve the consistency and efficacy of probiotic-fortified foods by enabling safer delivery to target regions of the gastrointestinal tract. We evaluated a probiotic snack bite containing microencapsulated Lacticaseibacillus rhamnosus GG. Twenty-five healthy adults consumed one snack daily for 28 days, then a 7-day washout, followed by crossover. Outcomes included gastrointestinal health analysis, bowel movement ease and frequency, bloating, overall gut comfort, shotgun metagenomics and systemic biomarkers of barrier, brain function and inflammation. Compared with the lower-fibre control snack, the probiotic snack was associated with easier bowel movements and fewer constipation reports at end of period, while bloating remained low in both periods. However, because the products differed in nutritional composition, these findings cannot be attributed to L. rhamnosus GG alone inflammatory and barrier biomarkers did not differ between treatments and stayed within healthy ranges. In an exploratory subgroup with elevated baseline serotonin, end-of-period serotonin was lower after the probiotic-containing snack than after the control snack, whereas brain-derived neurotrophic factor was unchanged. Daily intake of microencapsulated Lacticaseibacillus rhamnosus GG was well tolerated and was associated with exploratory difference in bowel habit and serum serotonin in a subgroup, without detectable changes in systemic inflammation or barrier biomarkers.
- 20 August 2026
- Published by Walter de Gruyter GmbH in Beneficial Microbes
- p. 1-19
Open AccessA high-fibre snack containing Lacticaseibacillus rhamnosus GG for healthy adults: a randomised, double-blind, placebo-controlled crossover trial
Probiotics have gained increasing evidence for their roles in health and disease. Microencapsulation can improve the consistency and efficacy of probiotic-fortified foods by enabling safer delivery to target regions of the gastrointestinal tract. We evaluated a probiotic snack bite containing microencapsulated Lacticaseibacillus rhamnosus GG. Twenty-five healthy adults consumed one snack daily for 28 days, then a 7-day washout, followed by crossover. Outcomes included gastrointestinal health analysis, bowel movement ease and frequency, bloating, overall gut comfort, shotgun metagenomics and systemic biomarkers of barrier, brain function and inflammation. Compared with the lower-fibre control snack, the probiotic snack was associated with easier bowel movements and fewer constipation reports at end of period, while bloating remained low in both periods. However, because the products differed in nutritional composition, these findings cannot be attributed to L. rhamnosus GG alone inflammatory and barrier biomarkers did not differ between treatments and stayed within healthy ranges. In an exploratory subgroup with elevated baseline serotonin, end-of-period serotonin was lower after the probiotic-containing snack than after the control snack, whereas brain-derived neurotrophic factor was unchanged. Daily intake of microencapsulated Lacticaseibacillus rhamnosus GG was well tolerated and was associated with exploratory difference in bowel habit and serum serotonin in a subgroup, without detectable changes in systemic inflammation or barrier biomarkers.
- Open Access
- 8 July 2026
- Published by Oxford University Press (OUP) in SLEEP Advances
- Vol. 7 (3)
Peripheral sex differences in serum serotonin modulation in habitual short sleepers: an exploratory randomized trial of encapsulated Lacticaseibacillus rhamnosus GG
Sleep restriction, serotonin biology, and gut-brain signaling are interconnected, but whether habitual short sleep is associated with altered peripheral serotonin in healthy adults remains unclear. Probiotic modulation of circulating serotonin has also been insufficiently characterized. In this exploratory randomized, double-blind, placebo-controlled study, 21 healthy adults received microencapsulated Lacticaseibacillus rhamnosus GG or placebo for 28 days and were classified by habitual sleep duration as short sleepers (≤5 h/night) or adequate sleepers (≥6 h/night). Fasting serum serotonin was measured at baseline and day 28. Habitual short sleep was not associated with elevated serum serotonin. Female sex was associated with higher adjusted day-28 serum 5-HT in the primary winsorized log-transformed ANCOVA model (Type II ANOVA: F = 6.04, p = .03, partial η2 = 0.29), whereas treatment and sleep group did not show evidence of association. Although no statistically detectable independent probiotic effect was identified in this small exploratory sample. Directional decreases were observed in some participants with higher baseline serotonin values. These findings suggest that sex may be an important source of variation in peripheral serotonin and support further adequately powered studies using objective sleep phenotyping and prespecified sex-stratified analyses.
- 8 July 2026
- Published by Oxford University Press (OUP) in SLEEP Advances
- Vol. 7 (3)
Open AccessPeripheral sex differences in serum serotonin modulation in habitual short sleepers: an exploratory randomized trial of encapsulated Lacticaseibacillus rhamnosus GG
Sleep restriction, serotonin biology, and gut-brain signaling are interconnected, but whether habitual short sleep is associated with altered peripheral serotonin in healthy adults remains unclear. Probiotic modulation of circulating serotonin has also been insufficiently characterized. In this exploratory randomized, double-blind, placebo-controlled study, 21 healthy adults received microencapsulated Lacticaseibacillus rhamnosus GG or placebo for 28 days and were classified by habitual sleep duration as short sleepers (≤5 h/night) or adequate sleepers (≥6 h/night). Fasting serum serotonin was measured at baseline and day 28. Habitual short sleep was not associated with elevated serum serotonin. Female sex was associated with higher adjusted day-28 serum 5-HT in the primary winsorized log-transformed ANCOVA model (Type II ANOVA: F = 6.04, p = .03, partial η2 = 0.29), whereas treatment and sleep group did not show evidence of association. Although no statistically detectable independent probiotic effect was identified in this small exploratory sample. Directional decreases were observed in some participants with higher baseline serotonin values. These findings suggest that sex may be an important source of variation in peripheral serotonin and support further adequately powered studies using objective sleep phenotyping and prespecified sex-stratified analyses.
- 19 May 2026
- Published by Elsevier in Food and Chemical Toxicology
- Vol. 214, 116128
Maternal rebaudioside A and acesulfame-K exposure reprograms offspring submandibular gland development in a sex-dependent manner
- 19 May 2026
- Published by Elsevier in Food and Chemical Toxicology
- Vol. 214, 116128
Maternal rebaudioside A and acesulfame-K exposure reprograms offspring submandibular gland development in a sex-dependent manner
- Open Access
- 17 April 2026
- Published by MDPI AG in Lipidology
- Vol. 3 (2) , 13
Preparative Isolation of High-Purity n-3 Docosapentaenoic Acid via Iterative Isocratic Flash Chromatography with Solvent Recycling
Background: n-3 Docosapentaenoic acid (DPA; 22:5 n-3) is increasingly viewed as a distinct long-chain omega-3 fatty acid with biological activities that are not fully captured by eicosapentaenoic acid (EPA) or docosahexaenoic acid (DHA). However, progress remains limited by restricted access to high-purity DPA: most commercial sources contain DPA as a minor component, and published isolation strategies often yield only enriched mixtures or require multi-step workflows that are difficult to scale in standard laboratories. Objectives: We aimed to establish a robust, laboratory-accessible purification workflow to obtain DPA ethyl ester at high purity while preserving oxidative quality. Methods: Candidate lipid sources were screened to select an optimal DPA-containing feedstock. Oils were stabilized with antioxidants and pre-fractionated by cold crystallization (−20 °C) to reduce saturated lipids and oxidation by-products. Preparative separation used a stacked C18 flash system (15 μm + 45 μm in series) operated isocratically (methanol/water 92:8, v/v) at 120 mL/min. Fractions were analyzed by GC and iteratively reinjected to progressively enrich the DPA window. Solvent was recovered by distillation and reused. Results: Omegavie® 4020EE (5.4% n-3 DPA) was identified as the best starting material. Pretreatment eliminated detectable TBARS-derived malondialdehyde. The isocratic purification-loop strategy produced tens of grams of DPA ethyl ester at >98% purity (GC–FID) defined as n-3 DPA area% of total identified fatty acid methyl esters by GC–FID, with per-cycle DPA recovery of 91–95%, overall recovery of 76% from the starting DPA content, and >90% solvent recycling. The workflow is scalable at the gram-to-tens-of-grams level for research laboratories, although solvent burden and column maintenance remain practical constraints for larger-scale implementation. Identity and purity were confirmed by GC–MS and ^1H NMR, and oxidation indices remained low (peroxide value < 0.2 meq/kg; p-anisidine < 3). Conclusions: This scalable, solvent-conscious protocol enables reliable access to high-purity DPA and should be adaptable to other low-abundance polyunsaturated fatty acids.
- 17 April 2026
- Published by MDPI AG in Lipidology
- Vol. 3 (2) , 13
Open AccessPreparative Isolation of High-Purity n-3 Docosapentaenoic Acid via Iterative Isocratic Flash Chromatography with Solvent Recycling
Background: n-3 Docosapentaenoic acid (DPA; 22:5 n-3) is increasingly viewed as a distinct long-chain omega-3 fatty acid with biological activities that are not fully captured by eicosapentaenoic acid (EPA) or docosahexaenoic acid (DHA). However, progress remains limited by restricted access to high-purity DPA: most commercial sources contain DPA as a minor component, and published isolation strategies often yield only enriched mixtures or require multi-step workflows that are difficult to scale in standard laboratories. Objectives: We aimed to establish a robust, laboratory-accessible purification workflow to obtain DPA ethyl ester at high purity while preserving oxidative quality. Methods: Candidate lipid sources were screened to select an optimal DPA-containing feedstock. Oils were stabilized with antioxidants and pre-fractionated by cold crystallization (−20 °C) to reduce saturated lipids and oxidation by-products. Preparative separation used a stacked C18 flash system (15 μm + 45 μm in series) operated isocratically (methanol/water 92:8, v/v) at 120 mL/min. Fractions were analyzed by GC and iteratively reinjected to progressively enrich the DPA window. Solvent was recovered by distillation and reused. Results: Omegavie® 4020EE (5.4% n-3 DPA) was identified as the best starting material. Pretreatment eliminated detectable TBARS-derived malondialdehyde. The isocratic purification-loop strategy produced tens of grams of DPA ethyl ester at >98% purity (GC–FID) defined as n-3 DPA area% of total identified fatty acid methyl esters by GC–FID, with per-cycle DPA recovery of 91–95%, overall recovery of 76% from the starting DPA content, and >90% solvent recycling. The workflow is scalable at the gram-to-tens-of-grams level for research laboratories, although solvent burden and column maintenance remain practical constraints for larger-scale implementation. Identity and purity were confirmed by GC–MS and ^1H NMR, and oxidation indices remained low (peroxide value < 0.2 meq/kg; p-anisidine < 3). Conclusions: This scalable, solvent-conscious protocol enables reliable access to high-purity DPA and should be adaptable to other low-abundance polyunsaturated fatty acids.
- 26 March 2026
- Published by Oxford University Press (OUP) in Journal of AOAC INTERNATIONAL
- Vol. 109 (5) , 763-773
Enumeration of Heat-Treated Probiotics in Functional Beverages
Background: Thermal processing of functional beverages often drives probiotics into a viable but non-culturable (VBNC) state, causing severe underestimation by conventional colony-forming unit (CFU) assays. Objective: To develop and assess an anaerobic, catalase-assisted resuscitation approach that restores culturability of heat-stressed Lacticaseibacillus rhamnosus GG and aligns CFU counts with actual viable populations. Methods: Dairy beverages (95°C, 30 s; 2 × 106 cells/mL, pH 3.9) containing encapsulated L. rhamnosus GG were incubated at 37°C for 16 h in Rogosa/MRS broth supplemented with 50–100 U/mL catalase under anaerobic conditions before plating. Recovery was benchmarked against flow cytometry (active fluorescent units AFU), whereas pH and glucose monitoring confirmed resuscitation rather than growth. Method performance was examined across three production batches (single-laboratory study) and further evaluated in a multilaboratory setting. Results: Direct plating yielded no CFU, whereas flow cytometry detected 6.34 ± 0.04 log10 AFU/g. After resuscitation, CFU recovered to 6.05 ± 0.05 log10/g (CFU/AFU ratio = 0.86 ± 0.03; P = 0.12). Omitting catalase or anaerobiosis reduced recovery by >1.9 log10 CFU/g. CFU restoration occurred without acidification or glucose depletion, confirming true resuscitation. Single-laboratory reproducibility showed CV < 2%; interlaboratory reproducibility was <15% RSD. Application to heat-treated milk (pH 6.85) yielded 1.74 × 106 CFU/g (CV 15.9%, n = 4), supporting method suitability across other dairy beverages. Conclusion: The catalase-assisted, anaerobic resuscitation developed protocol provides a reproducible workflow for probiotic enumeration in heat-treated beverages. The method is compatible with AOAC/ISO standards, addresses underestimation of counts, and supports adoption into quality control (QC) laboratories for accurate probiotic labeling. Highlights: Heat-stressed L. rhamnosus GG cells recovered culturability when incubated with catalase under anaerobic conditions, restoring CFU counts to AFU-equivalent levels and confirming true resuscitation rather than growth.
- 26 March 2026
- Published by Oxford University Press (OUP) in Journal of AOAC INTERNATIONAL
- Vol. 109 (5) , 763-773
Enumeration of Heat-Treated Probiotics in Functional Beverages
Background: Thermal processing of functional beverages often drives probiotics into a viable but non-culturable (VBNC) state, causing severe underestimation by conventional colony-forming unit (CFU) assays. Objective: To develop and assess an anaerobic, catalase-assisted resuscitation approach that restores culturability of heat-stressed Lacticaseibacillus rhamnosus GG and aligns CFU counts with actual viable populations. Methods: Dairy beverages (95°C, 30 s; 2 × 106 cells/mL, pH 3.9) containing encapsulated L. rhamnosus GG were incubated at 37°C for 16 h in Rogosa/MRS broth supplemented with 50–100 U/mL catalase under anaerobic conditions before plating. Recovery was benchmarked against flow cytometry (active fluorescent units AFU), whereas pH and glucose monitoring confirmed resuscitation rather than growth. Method performance was examined across three production batches (single-laboratory study) and further evaluated in a multilaboratory setting. Results: Direct plating yielded no CFU, whereas flow cytometry detected 6.34 ± 0.04 log10 AFU/g. After resuscitation, CFU recovered to 6.05 ± 0.05 log10/g (CFU/AFU ratio = 0.86 ± 0.03; P = 0.12). Omitting catalase or anaerobiosis reduced recovery by >1.9 log10 CFU/g. CFU restoration occurred without acidification or glucose depletion, confirming true resuscitation. Single-laboratory reproducibility showed CV < 2%; interlaboratory reproducibility was <15% RSD. Application to heat-treated milk (pH 6.85) yielded 1.74 × 106 CFU/g (CV 15.9%, n = 4), supporting method suitability across other dairy beverages. Conclusion: The catalase-assisted, anaerobic resuscitation developed protocol provides a reproducible workflow for probiotic enumeration in heat-treated beverages. The method is compatible with AOAC/ISO standards, addresses underestimation of counts, and supports adoption into quality control (QC) laboratories for accurate probiotic labeling. Highlights: Heat-stressed L. rhamnosus GG cells recovered culturability when incubated with catalase under anaerobic conditions, restoring CFU counts to AFU-equivalent levels and confirming true resuscitation rather than growth.
- 31 January 2026
- Published by Oxford University Press (OUP) in Journal of AOAC INTERNATIONAL
New Insights into Probiotic Enumeration in a Complex Food Matrix: Flow Cytometry and Plate Count Correlation
Background: Accurate probiotic enumeration ensures the dose delivered to the mammalian host. Plate count (PC) detects only culturable cells and can underestimate the total number of viable cells, particularly when some cells are injured or dormant and do not form colonies. Objective: To qualify a flow cytometry assay reporting active fluorescent units (AFU) and to compare counts with the PC method for micro-encapsulated Lacticaseibacillus rhamnosus GG in a snack product. Methods: Following AOAC INTERNATIONAL, International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH), and United States Pharmacopeia (USP) principles, precision, accuracy, ruggedness, specificity, and robustness of plate count and flow cytometry methods were evaluated for the first time in a commercial yogurt-bite snack product. Results: Both methods fulfilled the pre-specified performance targets (RSD ≤15%; AFU recovery 100–104%; live/dead R2 ≥0.95). Analyst-to-analyst differences were not significant. Flow cytometry spike recoveries were 100–104% across targets. Live/dead mixtures tracked linearly (R2 ≥0.95). Across matched samples, AFU and CFU values were equivalent within a pre-specified ±0.5 log band; batch means typically differed by ≤0.2 log with no systematic bias. Conclusion: The qualified flow cytometry method provides same-day counts and enumerates all membrane-intact cells, complementing plate counts while meeting analytical performance criteria. Findings endorse the use of AFU in tandem to CFU assessment for probiotic quantification, label accuracy and estimation of microbiome-relevant dose in snack and finished-product matrixes. Highlights: Flow cytometry provided same-day results and enumerated all membrane-intact cells for label verification in snack matrixes.
- 31 January 2026
- Published by Oxford University Press (OUP) in Journal of AOAC INTERNATIONAL
New Insights into Probiotic Enumeration in a Complex Food Matrix: Flow Cytometry and Plate Count Correlation
Background: Accurate probiotic enumeration ensures the dose delivered to the mammalian host. Plate count (PC) detects only culturable cells and can underestimate the total number of viable cells, particularly when some cells are injured or dormant and do not form colonies. Objective: To qualify a flow cytometry assay reporting active fluorescent units (AFU) and to compare counts with the PC method for micro-encapsulated Lacticaseibacillus rhamnosus GG in a snack product. Methods: Following AOAC INTERNATIONAL, International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH), and United States Pharmacopeia (USP) principles, precision, accuracy, ruggedness, specificity, and robustness of plate count and flow cytometry methods were evaluated for the first time in a commercial yogurt-bite snack product. Results: Both methods fulfilled the pre-specified performance targets (RSD ≤15%; AFU recovery 100–104%; live/dead R2 ≥0.95). Analyst-to-analyst differences were not significant. Flow cytometry spike recoveries were 100–104% across targets. Live/dead mixtures tracked linearly (R2 ≥0.95). Across matched samples, AFU and CFU values were equivalent within a pre-specified ±0.5 log band; batch means typically differed by ≤0.2 log with no systematic bias. Conclusion: The qualified flow cytometry method provides same-day counts and enumerates all membrane-intact cells, complementing plate counts while meeting analytical performance criteria. Findings endorse the use of AFU in tandem to CFU assessment for probiotic quantification, label accuracy and estimation of microbiome-relevant dose in snack and finished-product matrixes. Highlights: Flow cytometry provided same-day results and enumerated all membrane-intact cells for label verification in snack matrixes.
- Open Access
- 19 January 2026
- Published by MDPI AG in Preprints.org
Preparative Isolation of High-Purity n-3 Docosapentaenoic Acid via Iterative Isocratic Flash Chromatography with Solvent Recycling
Background: n-3 Docosapentaenoic acid (DPA; 22:5 n-3) is increasingly viewed as a distinct long-chain omega-3 fatty acid with biological activities that are not fully captured by EPA or DHA. However, progress remains limited by restricted access to high-purity DPA: most commercial sources contain DPA as a minor component, and published isolation strategies often yield only enriched mixtures or require multi-step workflows that are difficult to scale in standard laboratories. Objectives: To establish a robust, laboratory-accessible purification workflow to obtain DPA ethyl ester at high purity while preserving oxidative quality. Methods: Candidate lipid sources were screened to select an optimal DPA-containing feedstock. Oils were stabilized with antioxidants and pre-fractionated by cold crystallization (−20 °C) to reduce saturated lipids and oxidation by-products. Preparative separation used a stacked C18 flash system (15 μm + 45 μm in series) operated isocratically (methanol/water 92:8, v/v) at 120 mL/min. Fractions were analyzed by GC and iteratively reinjected to progressively enrich the DPA window. Solvent was recovered by distillation and reused. Results: Omegavie® 4020EE (6.6% DPA) was identified as the best starting material. Pretreatment eliminated detectable TBARS-derived malondialdehyde. The isocratic purification-loop strategy produced tens of grams of DPA ethyl ester at >98% purity (GC–FID) with high overall recovery (~90%) and >90% solvent recycling. Identity and purity were confirmed by GC–MS and ^1H NMR, and oxidation indices remained low (peroxide value < 0.2 meq/kg; p-anisidine < 3). Conclusions: This scalable, solvent-conscious protocol enables reliable access to high-purity DPA and should be adaptable to other low-abundance polyunsaturated fatty acids.
- 19 January 2026
- Published by MDPI AG in Preprints.org
Open AccessPreparative Isolation of High-Purity n-3 Docosapentaenoic Acid via Iterative Isocratic Flash Chromatography with Solvent Recycling
Background: n-3 Docosapentaenoic acid (DPA; 22:5 n-3) is increasingly viewed as a distinct long-chain omega-3 fatty acid with biological activities that are not fully captured by EPA or DHA. However, progress remains limited by restricted access to high-purity DPA: most commercial sources contain DPA as a minor component, and published isolation strategies often yield only enriched mixtures or require multi-step workflows that are difficult to scale in standard laboratories. Objectives: To establish a robust, laboratory-accessible purification workflow to obtain DPA ethyl ester at high purity while preserving oxidative quality. Methods: Candidate lipid sources were screened to select an optimal DPA-containing feedstock. Oils were stabilized with antioxidants and pre-fractionated by cold crystallization (−20 °C) to reduce saturated lipids and oxidation by-products. Preparative separation used a stacked C18 flash system (15 μm + 45 μm in series) operated isocratically (methanol/water 92:8, v/v) at 120 mL/min. Fractions were analyzed by GC and iteratively reinjected to progressively enrich the DPA window. Solvent was recovered by distillation and reused. Results: Omegavie® 4020EE (6.6% DPA) was identified as the best starting material. Pretreatment eliminated detectable TBARS-derived malondialdehyde. The isocratic purification-loop strategy produced tens of grams of DPA ethyl ester at >98% purity (GC–FID) with high overall recovery (~90%) and >90% solvent recycling. Identity and purity were confirmed by GC–MS and ^1H NMR, and oxidation indices remained low (peroxide value < 0.2 meq/kg; p-anisidine < 3). Conclusions: This scalable, solvent-conscious protocol enables reliable access to high-purity DPA and should be adaptable to other low-abundance polyunsaturated fatty acids.
- Open Access
- 30 October 2025
- Published by MDPI AG in Microorganisms
- Vol. 13 (11) , 2479
Probiotic Viability Reconsidered: Integrating VBNC Resuscitation and Culture-Independent Methods for Accurate Probiotic Enumeration
Probiotic enumeration in foods and beverages remains anchored in culture dependent colony-forming unit (CFU) counts, the regulatory gold standard for label compliance. However, culturability does not fully equate to viability as environmental stresses can convert probiotic cells into a viable but non-culturable (VBNC) state, where they remain metabolically active but undetectable by CFU counts. Microencapsulation can provide a degree of protection to probiotics against stress; nevertheless, this blind spot in quantification forces manufacturers to overdose formulations or risk non-compliance with health benefits claims. Thus, the efficacy of probiotics may be underestimated when evaluation relies solely on CFU, creating a false dichotomy between VBNC and non-viable cells. Culture-independent methods, including flow cytometry quantification of active fluorescent units (AFUs), viability PCR/dPCR, and rRNA-targeted Flow-FISH, can aid closing this gap by detecting metabolically active cells non-detectable by culturing, providing complementary quantification data to CFU counts alone. Understanding the relationship between quantification by culture and culture-independent methods provides a more accurate measure of probiotic dose delivery in functional foods and beverages. This review covers the current understanding of VBNC state, including induction, detection, and resuscitation in probiotics, with emphasis on experimental controls that differentiate true VBNC resuscitation from population growth. Case studies in Lactobacillus and Bifidobacterium illustrate triggers, molecular mechanisms, and methodological advances. Finally, guidance is provided for the development of an integrated quantification approach that reconciles culture-dependent and culture-independent data, ultimately aiming to improve CFU count accuracy through the controlled resuscitation of VBNC cells.
- 30 October 2025
- Published by MDPI AG in Microorganisms
- Vol. 13 (11) , 2479
Open AccessProbiotic Viability Reconsidered: Integrating VBNC Resuscitation and Culture-Independent Methods for Accurate Probiotic Enumeration
Probiotic enumeration in foods and beverages remains anchored in culture dependent colony-forming unit (CFU) counts, the regulatory gold standard for label compliance. However, culturability does not fully equate to viability as environmental stresses can convert probiotic cells into a viable but non-culturable (VBNC) state, where they remain metabolically active but undetectable by CFU counts. Microencapsulation can provide a degree of protection to probiotics against stress; nevertheless, this blind spot in quantification forces manufacturers to overdose formulations or risk non-compliance with health benefits claims. Thus, the efficacy of probiotics may be underestimated when evaluation relies solely on CFU, creating a false dichotomy between VBNC and non-viable cells. Culture-independent methods, including flow cytometry quantification of active fluorescent units (AFUs), viability PCR/dPCR, and rRNA-targeted Flow-FISH, can aid closing this gap by detecting metabolically active cells non-detectable by culturing, providing complementary quantification data to CFU counts alone. Understanding the relationship between quantification by culture and culture-independent methods provides a more accurate measure of probiotic dose delivery in functional foods and beverages. This review covers the current understanding of VBNC state, including induction, detection, and resuscitation in probiotics, with emphasis on experimental controls that differentiate true VBNC resuscitation from population growth. Case studies in Lactobacillus and Bifidobacterium illustrate triggers, molecular mechanisms, and methodological advances. Finally, guidance is provided for the development of an integrated quantification approach that reconciles culture-dependent and culture-independent data, ultimately aiming to improve CFU count accuracy through the controlled resuscitation of VBNC cells.
- Open Access
The dietary emulsifier polysorbate-80 induces lipid accumulation and cell death in intestinal epithelial cells via ferroptosis
Summary: Chronic inflammatory and metabolic diseases are major global health issues increasingly linked to dietary factors. Consumption of dietary emulsifiers like polysorbate-80 (p80), common in ultra-processed foods and pharmaceuticals, has raised concerns about gut health. RNA sequencing on intestinal epithelial cells (IECs) exposed to p80 revealed increased expression of ferroptosis-associated genes and disruption of lipid metabolism pathways further demonstrated by mitochondrial dysfunction, including altered membrane potential and architecture, and accumulation of reactive oxygen species, iron, lipid peroxidation, and lipid droplet formation. Lipidomic profiling identified significant alterations in triglyceride species and elevated pro-ferroptotic polyunsaturated fatty acids. These data indicate that p80 disrupts lipid homeostasis in IECs and triggers ferroptotic cell death, mechanisms potentially contributing to the increased incidence of chronic conditions like inflammatory bowel disease and metabolic syndrome. The study highlights critical implications for public health, emphasizing the need for reassessment of emulsifier safety standards while balancing needs with consumer safety.
Open AccessThe dietary emulsifier polysorbate-80 induces lipid accumulation and cell death in intestinal epithelial cells via ferroptosis
Summary: Chronic inflammatory and metabolic diseases are major global health issues increasingly linked to dietary factors. Consumption of dietary emulsifiers like polysorbate-80 (p80), common in ultra-processed foods and pharmaceuticals, has raised concerns about gut health. RNA sequencing on intestinal epithelial cells (IECs) exposed to p80 revealed increased expression of ferroptosis-associated genes and disruption of lipid metabolism pathways further demonstrated by mitochondrial dysfunction, including altered membrane potential and architecture, and accumulation of reactive oxygen species, iron, lipid peroxidation, and lipid droplet formation. Lipidomic profiling identified significant alterations in triglyceride species and elevated pro-ferroptotic polyunsaturated fatty acids. These data indicate that p80 disrupts lipid homeostasis in IECs and triggers ferroptotic cell death, mechanisms potentially contributing to the increased incidence of chronic conditions like inflammatory bowel disease and metabolic syndrome. The study highlights critical implications for public health, emphasizing the need for reassessment of emulsifier safety standards while balancing needs with consumer safety.